• Return to Headlines

Shares of PTCT Up 36.6% Since Uptrend Call on Shares

By Amy Schwartz

SmarTrend identified an Uptrend for Ptc Therapeutics (NASDAQ:PTCT) on February 22nd, 2019 at $32.16. In approximately 6 months, Ptc Therapeutics has returned 36.59% as of today's recent price of $43.92.

In the past 52 weeks, Ptc Therapeutics share prices have been bracketed by a low of $27.53 and a high of $48.99 and are now at $43.92, 60% above that low price. The 200-day and 50-day moving averages have moved 0.42% higher and 0.86% higher over the past week, respectively.

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients; and Emflaza (deflazacort) for treating Duchenne muscular dystrophy.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Ptc Therapeutics shares.

Log in and add Ptc Therapeutics (PTCT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ptc therapeutics

Ticker(s): PTCT